What Is Pediatrix Medical Group, Inc. (MD) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Pediatrix Medical Group, Inc.'s intrinsic value is estimated at a composite fair value of $40.50. While the stock appears modestly undervalued at $24.11 (implied upside of +68.0%), our analysis suggests a thinner margin of safety across 8 of 12 bullish models. Notably, Markov DDM sees the most upside at +444.4% (fair value: $131.26), while EROIC is the most conservative at -12.2% ($21.18). The spread between these extremes — +456.6% — reveals how different analytical frameworks can reach starkly different conclusions. Among models with highest confidence, EPV lean bullish — adding weight to the bullish side of the thesis.
What Do the Models Say About MD?
12 of 13 models are currently active for MD. Of these, 8 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates MD's intrinsic value at $23.45, implying -2.7% downside from the current price. See which stocks rank higher →
How Does MD Rank in Services-Hospitals?
Among 2 Services-Hospitals stocks, MD ranks #2 by Quality of Company score. CirclFi's QOC score of 6.4/10 evaluates 32 fundamental signals. A score of 6.4 indicates above-average quality.
Pediatrix Medical Group, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is MD a Value Trap?
CirclFi's Value Trap algorithm assigns MD a score of 21/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Pediatrix Medical Group, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Pediatrix Medical Group, Inc.'s fundamental quality profile registers 6.4/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +456.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every MD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across MD's 12 active models, average confidence is 43%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →